Versatile Anti-human Respiratory Syncytial Virus(rsv) Fusion Glycoprotein/rsv-f Monoclonal Antibody Web Only Deal [W8iasBn7]

Anti-Human Respiratory Syncytial Virus (RSV) Fusion Glycoprotein Monoclonal Antibody

Introducing our cutting-edge Anti-Human Respiratory Syncytial Virus (RSV) Fusion Glycoprotein Monoclonal Antibody, a powerful tool for research and diagnostics. This monoclonal antibody is specifically designed to target the RSV fusion glycoprotein, making it an invaluable asset for researchers studying this virus. With its high specificity and sensitivity, this antibody is ideal for a variety of applications, including ELISA, providing accurate and reliable results.

Product Specifications and Features

Our RSV Fusion Glycoprotein Monoclonal Antibody is produced in rabbits, offering a robust and reliable source of antigen-specific antibodies. The antibody is conjugated with IgG, ensuring compatibility with various immunological assays. Key features include:

Isotype: IgG

Host: Rabbit

Reactivity: RSV

Applications: ELISA

Clonality: Monoclonal

Immunogen: Recombinant RSV (A2) Fusion glycoprotein / RSV-F Protein (His Tag)

Synonyms: F, HRSVgp08

Concentration: 1 mg/mL

Buffer: 0.2 μm filtered solution in PBS

Purification Method: Protein A Affinity

Clone No.: 009

Conjugation: Unconjugated

Storage: Store at -20°C Valid for 12 months. Avoid freeze/thaw cycles.

Shipping: The product is shipped with ice pack; upon receipt, store it immediately at the recommended temperature.

Applications and Benefits

The Anti-Human Respiratory Syncytial Virus (RSV) Fusion Glycoprotein Monoclonal Antibody is a versatile tool for researchers and healthcare professionals. It is particularly beneficial for:

ELISA Assays: The antibody's high specificity and sensitivity make it ideal for detecting RSV in various samples, including serum, plasma, and cell culture supernatants.

Research and Diagnostics: This antibody is a valuable resource for studying RSV and its role in respiratory infections, aiding in the development of new diagnostic tools and therapeutic strategies.

By utilizing our RSV Fusion Glycoprotein Monoclonal Antibody, you can enhance your research capabilities and contribute to the ongoing fight against respiratory syncytial virus infections.